About Revolution Medicines
Revolution Medicines is a company based in Redwood City (United States) founded in 2014 by Kevan Shokat, Michael Fischbach, and Martin Burke.. Revolution Medicines has raised $326.29 million across 5 funding rounds from investors including The Column Group, Cormorant Capital and Deerfield. The company has 534 employees as of December 31, 2024. Revolution Medicines has completed 2 acquisitions, including EQRx and Warp Drive Bio. Revolution Medicines offers products and services including Drug Pipeline. Revolution Medicines operates in a competitive market with competitors including Jazz Pharmaceuticals, C4 Therapeutics, Erasca, MiRagen and Mereo BioPharma, among others.
- Headquarter Redwood City, United States
- Employees 534 as on 31 Dec, 2024
- Founders Kevan Shokat, Michael Fischbach, Martin Burke
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Revolution Medicines, Inc.
-
Annual Revenue
$0-100as on Dec 31, 2024
-
Net Profit
$-600.09 M-37.52as on Dec 31, 2024
-
EBITDA
$-677.7 M-41.82as on Dec 31, 2024
-
Total Equity Funding
$326.29 M (USD)
in 5 rounds
-
Latest Funding Round
$100.29 M (USD), Series C
Nov 13, 2019
-
Investors
The Column Group
& 8 more
-
Employee Count
534
as on Dec 31, 2024
-
Investments & Acquisitions
EQRx
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Revolution Medicines
Revolution Medicines is a publicly listed company on the NASDAQ with ticker symbol RVMD in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Revolution Medicines
Revolution Medicines offers a comprehensive portfolio of products and services, including Drug Pipeline. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
System for advancing cancer treatment therapies through scientific innovation
Unlock access to complete
Unlock access to complete
Leadership Team
103 people
Senior Team
24 people
Operations Team
21 people
Software Development Team
17 people
Product Management Team
12 people
Data Analysis and Operations Team
12 people
Legal and Compliance
8 people
Sr. Team
7 people
Unlock access to complete
Funding Insights of Revolution Medicines
Revolution Medicines has successfully raised a total of $326.29M across 5 strategic funding rounds. The most recent funding activity was a Series C round of $100.29 million completed in November 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series C — $100.3M
-
First Round
First Round
(04 Feb 2015)
- Investors Count 9
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2019 | Amount | Series C - Revolution Medicines | Valuation |
investors |
|
| Jul, 2019 | Amount | Series C - Revolution Medicines | Valuation | Boxer Capital | |
| Apr, 2018 | Amount | Series B - Revolution Medicines | Valuation | Nextech Invest |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Revolution Medicines
Revolution Medicines has secured backing from 9 investors, including institutional and venture fund investors. Prominent investors backing the company include The Column Group, Cormorant Capital and Deerfield. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare ecosystem is supported through investment and innovation by Deerfield.
|
Founded Year | Domain | Location | |
|
Venture capital and private equity firm
|
Founded Year | Domain | Location | |
|
PE firm investing in the US
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Revolution Medicines
Revolution Medicines has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include EQRx and Warp Drive Bio. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Drugs for undruggable cancers are discovered via proprietary platforms.
|
2012 | ||||
|
Medicines are manufactured by EQRx in the pharmaceutical industry.
|
2005 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Revolution Medicines
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Revolution Medicines Comparisons
Competitors of Revolution Medicines
Revolution Medicines operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, C4 Therapeutics, Erasca, MiRagen and Mereo BioPharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Small-molecule drugs for cancer treatment are developed via Degronimid platform.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
MicroRNA-based therapeutics are developed for treating multiple diseases.
|
|
| domain | founded_year | HQ Location |
Therapeutics for cancer and rare diseases are developed.
|
|
| domain | founded_year | HQ Location |
Targeted therapeutics for cancer, metabolic, and inflammatory diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Revolution Medicines
Frequently Asked Questions about Revolution Medicines
When was Revolution Medicines founded?
Revolution Medicines was founded in 2014 and raised its 1st funding round 1 year after it was founded.
Where is Revolution Medicines located?
Revolution Medicines is headquartered in Redwood City, United States. It is registered at Redwood City, California, United States.
Who is the current CEO of Revolution Medicines?
Mark A Goldsmith is the current CEO of Revolution Medicines.
Is Revolution Medicines a funded company?
Revolution Medicines is a funded company, having raised a total of $326.29M across 5 funding rounds to date. The company's 1st funding round was a Series B of $56M, raised on Feb 04, 2015.
How many employees does Revolution Medicines have?
As of Dec 31, 2024, the latest employee count at Revolution Medicines is 534.
What does Revolution Medicines do?
Revolution Medicines was founded in 2014 and is headquartered in Redwood City, United States. Targeted oncology therapies are developed by the company within the biotechnology sector. Operations center on inhibitors of signaling pathways, including RMC-4630 for SHP2 in RAS-related mutations and RMC-5552 for mTORC1 to preserve protein suppression of tumors. Clinical programs evaluate these for multiple tumor types across various geographies.
Who are the top competitors of Revolution Medicines?
Revolution Medicines's top competitors include Jazz Pharmaceuticals, C4 Therapeutics and Erasca.
What products or services does Revolution Medicines offer?
Revolution Medicines offers Drug Pipeline.
Is Revolution Medicines publicly traded?
Yes, Revolution Medicines is publicly traded on NASDAQ under the ticker symbol RVMD.
How many acquisitions has Revolution Medicines made?
Revolution Medicines has made 2 acquisitions, including EQRx, and Warp Drive Bio.
Who are Revolution Medicines's investors?
Revolution Medicines has 9 investors. Key investors include The Column Group, Cormorant Capital, Deerfield, Vivo Capital, and Nextech Invest.
What is Revolution Medicines's ticker symbol?
The ticker symbol of Revolution Medicines is RVMD on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.